Article
Genetic influence of plasma homocysteine on Alzheimer's disease.
Neurobiology of aging - 1 Feb 2018
Roostaei Tina, Felsky Daniel, Nazeri Arash, De Jager Philip L, Schneider Julie A, Bennett David A, Voineskos Aristotle N
Abstract excerpt
Observational studies have consistently reported elevated plasma homocysteine as a risk factor for Alzheimer's disease (AD). However, results from clinical trials of homocysteine-lowering treatments are inconsistent. This discrepancy may be explained by a lack of causal association between homocysteine and AD. Mendelian randomization studies have the potential to provide insight into the causality of this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
